Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Fingolimod | 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol | 162359-55-9 | C19H33NO2 | 307.47 | 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-d... |
| Fingolimod-D4 | 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol-d4; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol-d4; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol-d4 | 1346747-38-3 | C19H29D4NO2 | 311.5 | 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol-d4; 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol-d4; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane... |
| Fingolimod Palmitate Amide | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide | 1242271-26-6 | C35H63NO3 | 545.88 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide
|
| 3,4-Dehydro Cilostazol-d11 | 6-[4-(1-Cyclohexyl-d11-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone;OPC 13015-d11; | 1073608-13-5 | C20H14D11N5O2 | 378.51 | 6-[4-(1-Cyclohexyl-d11-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone;OPC 13015-d11;
|
| Fingolimod Palmitate Amide-d4 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide-d4 | C35H59D4NO3 | 549.9 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide-d4
| |
| Fingolimod Stearoate Amide | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide | 1242271-27-7 | C37H67NO3 | 573.93 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide
|
| delta 9,11-Dehydro-17 alpha-cyanomethyl Estradiol | (17 alpha)-3,17-Dihydroxy-19-norpregna-1,3,5(10),9(11)-tetraene-21-nitrile; 17 alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraene-3,17 beta-diol; STS 825 | 86153-38-0 | C20H23NO2 | 309.4 | (17 alpha)-3,17-Dihydroxy-19-norpregna-1,3,5(10),9(11)-tetraene-21-nitrile; 17 alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraene-3,17 beta-diol; STS 825... |
| delta 9,11-Dehydro-17 alpha-cyanomethyl Estradiol-13C,D2 | (17α)-3,17-Dihydroxy-19-norpregna-1,3,5(10),9(11)-tetraene-21-nitrile-13C,D2; 17 alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraene-3,17 beta-diol-13C,D2; | NA | C2013CD2H23NO2 | 312.41 | (17α)-3,17-Dihydroxy-19-norpregna-1,3,5(10),9(11)-tetraene-21-nitrile-13C,D2; 17 alpha-Cyanomethylestra-1,3,5(10),9(11)-tetraene-3,17 beta-diol-13C,D... |
| 4-Bromo-2-chlorobenzamide | 426265-73-8 | C7H5BrClNO | 234.48 | ||
| Lysipressin-d2 Trifluoroacetic Acid Salt | 19-Amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide-d2 Trifluoroacetic Acid Salt; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.-d2 Trifluoroacetic Acid Salt; 3-(Phenylalanine)-8-lysine Oxytocin-d2 Trifluoroacetic Acid Salt; 8-L-Lysine Vasopressin-d2 Trifluoroacetic Acid Salt; Diapid-d2 Trifluoroacetic Acid Salt; L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide-d2 Cyclic (1→6)-Disulfide; L-Lysine Vasopressin-d2; Lypressin-d2 Trifluoroacetic Acid Salt; Lysine Pitressin-d2 Trifluoroacetic Acid Salt; Lysine Vasopressin-d2 Trifluoroacetic A | NA | C46H63D2N13O12S2 • x(C 2HF3O2) | 1058.23114 | 19-Amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,... |
Page 1862 of 10017